v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (8,995) $ (5,458)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 4,948 4,189
Amortization of loan costs 1,209 384
Gain on settlement of liability 0 (295)
Loss on interest rate hedge 179 55
Loss on sale of real estate 0 42
Equity based payment 1,488 3,409
Impairment 0 157
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) (235) (964)
Changes in operating assets and liabilities    
Due to/from related parties 3 (18)
Accounts payable and accrued expenses 596 (1,566)
Other assets 853 459
Accounts receivable 195 (1,405)
Net cash provided by (used in) operating activities 241 (1,011)
Cash flows from investing activities:    
Capital expenditures (551) (351)
Insurance reimbursement for capital expenditures 120 0
Proceeds from note receivable 3,120 0
Payments on sale of investment in real estate 0 (155)
Net cash provided by (used in) investing activities 2,689 (506)
Cash flows from financing activities:    
Proceeds from Line of Credit 2,298 0
Payments on notes payable (1,455) (7,084)
Proceeds from notes payable 0 5,900
Distributions to non-controlling interest holders (93) (92)
Loan fees 0 (604)
Share repurchase plan (287) 0
Shares repurchased for vesting of employee awards (135) 0
Preferred redemption payments (2,693) 0
Preferred dividend payments (529) 0
Net cash used in financing activities (2,894) (1,880)
Net change in cash and cash equivalents and restricted cash 36 (3,397)
Cash and cash equivalents and restricted cash, beginning of period 15,819 16,711
Cash and cash equivalents and restricted cash, end of period 15,855 13,314
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 10,655 11,134
Restricted cash at beginning of period 5,164 5,577
Cash and cash equivalents and restricted cash, beginning of period 15,819 16,711
Cash and cash equivalents at end of period 10,621 8,690
Restricted cash at end of period 5,234 4,624
Cash and cash equivalents and restricted cash, end of period 15,855 13,314
Supplemental disclosures of cash flow information:    
Interest paid 5,881 5,721
Non-cash investing and financing activities:    
Distributions declared not yet paid 80 1,014
Requested preferred redemptions not yet paid 239
Accrued capital expenditures 89 16
Accrued preferred distributions paid in common stock 0 1,613
Right of use asset and lease liability 0 332
Note receivable related to disposition of property 0 3,120
Equity shares issued in exchange for accrued compensation $ 0 $ 1,301

Source

HTML PDF
ZIP